Clinical trial / 2001
Dietary supplementation with Bifidobacterium lactis HN019 enhanced cellular immune measures in healthy elderly subjects.
Thirty healthy elderly volunteers took part in a 9-week, 3-stage trial comprising a 3-week low-fat milk run-in, a 3-week intervention with milk supplemented with Bifidobacterium lactis HN019 (either 5 x 10^10 or 5 x 10^9 organisms/day), and a 3-week milk washout. Consumption of B. lactis HN019 led to increases in proportions of total, helper (CD4+), and activated (CD25+) T lymphocytes and natural killer cells. In addition, ex vivo phagocytic capacity of phagocytes and tumoricidal activity of natural killer cells were elevated, with the greatest changes seen in participants with poor pretreatment immune responses. The two doses showed similar effectiveness overall.
- Study type
- 3-stage dietary supplementation trial (run-in, intervention, washout)
- Who was studied
- 30 healthy elderly volunteers (age range: 63-84 y; median: 69 y)
- What was measured
- Changes in relative proportions of leukocyte subsets, ex vivo phagocytic activity, and natural killer tumor-cell-killing activity
THE PAPER
Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019.
Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Am J Clin Nutr, 2001.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.